183 related articles for article (PubMed ID: 6226490)
1. Systemic side-effects of three topical steroids in diseased skin.
Salde L; Lassus A
Curr Med Res Opin; 1983; 8(7):475-80. PubMed ID: 6226490
[TBL] [Abstract][Full Text] [Related]
2. A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis.
Schmidt H; Hjorth N; Salde L
J Int Med Res; 1981; 9(3):236-8. PubMed ID: 7016629
[TBL] [Abstract][Full Text] [Related]
3. Clinical comparison of halcinonide and betamethasone valerate in common dermatoses.
Turnbull BC
Australas J Dermatol; 1975 Apr; 16(1):17-9. PubMed ID: 1108858
[No Abstract] [Full Text] [Related]
4. Halcinonide, a new topical anti-inflammatory steroid.
Savin RC
J Int Med Res; 1976; 4(1):34-6. PubMed ID: 799976
[TBL] [Abstract][Full Text] [Related]
5. Influence of the base on the results of clinical trials with topical corticosteroids.
Vollum DI; Sparkes CG
Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
Clark RF; Clement ER
Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
[TBL] [Abstract][Full Text] [Related]
7. A double-blind trial of budesonide and betamethasone- 17,21-dipropionate in psoriasis.
Fredriksson T; Salde L
Curr Med Res Opin; 1982; 8(3):171-7. PubMed ID: 6751704
[TBL] [Abstract][Full Text] [Related]
8. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
Sharma SD
Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
[No Abstract] [Full Text] [Related]
9. Halomethasone (C 48.401-Ba) for the topical treatment of common dermatoses.
de la Brassine M; Kint A; Lachapelle JM; Tennstedt D
J Int Med Res; 1984; 12(5):307-9. PubMed ID: 6238861
[TBL] [Abstract][Full Text] [Related]
10. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
Gomez EC; Kaminester L; Frost P
Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and experimental studies on blood histamine levels in topical corticosteroid therapy].
Tanaka K
Nihon Hifuka Gakkai Zasshi; 1987 Feb; 97(2):125-36. PubMed ID: 2955146
[No Abstract] [Full Text] [Related]
12. Therapeutic uses of halcinonide.
Beveridge GW
Scott Med J; 1977 Jul; 22(3):231-3. PubMed ID: 329412
[No Abstract] [Full Text] [Related]
13. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Mensing H; Korsukewitz G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
[TBL] [Abstract][Full Text] [Related]
14. Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis.
Kostarelos K; Teknetzis A; Lefaki I; Ioannides D; Minas A
J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):5-9. PubMed ID: 10877245
[TBL] [Abstract][Full Text] [Related]
15. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
Shimao S
J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
[No Abstract] [Full Text] [Related]
16. Comparison of 0.1% halcinonide with 0.05% betamethasone dipropionate in the treatment of acute and chronic dermatoses.
Levy A
Curr Med Res Opin; 1977-1978; 5(4):328-32. PubMed ID: 343993
[TBL] [Abstract][Full Text] [Related]
17. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
Arbiser JL; Grossman K; Kaye E; Arndt KA
Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
[No Abstract] [Full Text] [Related]
18. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
Thormann J; Brodthagen H
Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
[TBL] [Abstract][Full Text] [Related]
19. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
[TBL] [Abstract][Full Text] [Related]
20. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Shupack JL; Jondreau L; Kenny C; Stiller MJ
Dermatology; 1993; 186(2):129-32. PubMed ID: 8428041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
